XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Stock-Based Compensation  
Schedule of stock option activity under the Equity Plans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

    

​

    

Average

    

Weighted

    

Aggregate

​

​

​

 

Exercise Price

 

Average Remaining

 

Intrinsic

​

​

Options

 

Per Share

​

Life in Years

​

Value

Outstanding at December 31, 2020

​

6,393,853

​

​

5.29

​

7.96

​

​

1,961

Granted

 

2,482,650

​

​

2.19

 

  

​

​

  

Exercised

 

(2,292)

​

​

1.55

 

​

​

​

​

Forfeited

​

(348,593)

​

​

3.17

​

​

​

​

​

Outstanding at December 31, 2021

 

8,525,618

​

​

4.48

 

7.58

​

​

7,673

Granted

 

4,024,900

​

​

1.50

 

  

​

​

  

Forfeited

​

(633,187)

​

​

2.17

​

​

​

​

​

Outstanding at December 31, 2022

​

11,917,331

​

​

3.59

​

7.47

​

​

​

Options exercisable at December 31, 2022

 

7,543,973

​

​

4.74

 

6.46

​

​

​

Options vested and expected to vest at December 31, 2022

 

11,917,331

​

​

3.59

 

7.47

​

​

​

​

Schedule of assumptions used to determine grant-date fair value of stock options

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

​

​

    

2022

    

2021

​

Expected volatility

 

82.70

%

67.64

%

Weighted average risk-free interest rate

 

3.10

%

0.82

%

Expected dividend yield

​

0.00

%

0.00

%

Expected term (in years)

​

6.42

​

6.82

​

​

Schedule of RSU activity under the 2016 Plan

​

​

​

​

​

​

​

​

​

​

 

Weighted

​

    

Number of

    

Average Grant

​

 

Shares

 

Date Fair Value

Outstanding at December 31, 2020

 

753,106

​

$

1.52

Awarded

​

275,000

​

$

2.57

Settled in cash

​

(92,500)

​

$

1.97

Outstanding at December 31, 2021

​

935,606

​

$

1.76

Awarded

 

2,650,000

​

$

1.94

Outstanding at December 31, 2022

 

3,585,606

​

$

1.89

​

Schedule of recognized stock-based compensation expense related to the issuance of stock option awards and RSUs to employees and non-employees in the condensed consolidated statements of operations

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31, 

​

    

2022

    

2021

Research and development

 

$

2,540

​

$

1,641

General and administrative

 

​

2,640

​

 

2,045

Total

​

$

5,180

​

$

3,686